Application note: Cell-Based Therapies – Be on the Safe Side
This Application note discusses how you can obtain on-time QC results within three hours to ensure your patient’s safety. It details the Microsart® ATMP Mycoplasma (a rapid real-time PCR mycoplasma detection kit for testing ATMPs) and the Microsart® ATMP Bacteria (for the sterility testing of cell culture samples including ATMPs).
Related content from this organisation
- Sartorius closes acquisition of selected assets of Danaher Life Sciences
- Active air sampler market to value $130.7 million by 2026
- Low costs of dispersible products to drive single-use bioprocessing market
- Intellectual property, divestments, fragmentation and the future: M&A in life sciences
- Viral vectors for gene therapy